Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Digital display devices and digital projectors with expanded color gamut
Rupture resistant system
Audio signal clip detection
Selecting input/output components of a mobile terminal
Micromechanical component, device for beam deflection of monochromatic light, and spectrometer
Irreversible thermochromic ink compositions
Secure Flash-based memory system with fast wipe feature
  Randomly Featured Patents
Hand tool for assembling a fiber optic connector
Differential for a vehicle axle
Method for managing status and dual information of clock distributor
Laser irradiation method, laser irradiation apparatus and method for manufacturing semiconductor device
Methods for producing antibodies which specifically bind to interleukin-9 receptor
Electronic pulse generation device
Viscous fluid heater
Lubricating oil composition
Buckle tensioner
Virtual or remote transponder